| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | -0.018 | 0.5 |
| mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.037 | 0.5 |
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | -0.021 | 0.5 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.035 | 0.5 |